The short-term use of luteinising hormone-releasing hormone analogues in uterine fibroids.
Twelve patients with uterine fibroids, who were due to undergo myomectomy, were treated preoperatively with the luteinising hormone-releasing hormone analogue, Zoladex. This resulted in a marked reduction in uterine and fibroid volume and surgery was facilitated.
Van der Spuy
Z M
ZM
Department of Obstetrics and Gynaecology, University of Cape Town Medical School, Observatory, South Africa.
Fieggan
A G
AG
Wood
M J
MJ
Pienaar
C A
CA
D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D017273:Goserelin; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery
D017273:Goserelin; D002064:Buserelin